Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Evaluation of Safety and Performance

NCT01627691 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT01627691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01627691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System - Evaluation of Safety and Performance
Lead sponsor
Boston Scientific Corporation
Phase
Not applicable
Overall status
Completed
Start date
October 8, 2012
Completion date
May 13, 2019
Enrollment
250 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

transcatheter aortic valve replacement